Search Results

You are looking at 1 - 10 of 37 items for :

  • "Guidelines" x
  • Thyroid cancer - clinical x
Clear All
Jiahui Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Close
,
Xunyang Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Close
,
Paula Seal EFW Radiology, Calgary, Alberta, Canada
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Paula Seal in
Google Scholar
PubMed
Close
,
Parthiv Amin Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Close
,
Brendan Diederichs Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Mayfair Radiology, Calgary, Alberta, Canada

Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Close
, and
Ralf Paschke Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

. and Grani et al. ( 5 , 6 ). In 2013, the European Thyroid Association (ETA) released POU guidelines for patients with thyroid cancer, which defined POU criteria for lymph node and thyroid bed nodule assessment ( 7 ). A retrospective assessment of

Open access
Luigino Dal Maso Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Close
,
Daniela Pierannunzio National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy

Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Close
,
Silvia Francisci National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy

Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Close
,
Angela De Paoli Epidemiological Department, Azienda Zero, Padova, Italy

Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Close
,
Federica Toffolutti Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Close
,
Salvatore Vaccarella Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France

Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Close
,
Silvia Franceschi Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Close
,
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Close
,
Ugo Fedeli Epidemiological Department, Azienda Zero, Padova, Italy

Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Close
, and
of the DEPTH Working Group
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
Close
of the DEPTH Working Group

Nuclear Medicine Department to perform this treatment. Beginning with the 2006 American Thyroid Association (ATA) guidelines, which were updated in 2009 and 2015, more selective use of RAI has been recommended ( 5 , 6 , 7 ). In 2009, RAI ablation was

Open access
Furio Pacini Section of Endocrinology, University of Siena, Siena, Italy

Search for other papers by Furio Pacini in
Google Scholar
PubMed
Close
,
Dagmar Fuhrer Department of Endocrinology, Diabetes and Metabolism, West German Cancer Centre (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany

Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Close
,
Rossella Elisei Section of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Close
,
Daria Handkiewicz-Junak Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland

Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Close
,
Sophie Leboulleux Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Close
,
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed
Close
,
Martin Schlumberger Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Close
, and
Johannes W Smit Radboud University Medical Center, Nijmegen, Netherlands

Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Close

-8587(1830113-X ) 8 Haugen BR Alexander EK Bible KC Doherty GM Mandel SJ Nikiforov YE Pacini F Randolph GW Sawka AM Schlumberger M 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and

Open access
Carla Gambale Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Carla Gambale in
Google Scholar
PubMed
Close
,
Alessandro Prete Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Close
,
Lea Contartese Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lea Contartese in
Google Scholar
PubMed
Close
,
Liborio Torregrossa Department of Surgical, Medical, Molecular Pathology and Critical Area, Anatomic Pathology Section, University Hospital of Pisa, Pisa, Italy

Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Close
,
Francesca Bianchi Department of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Close
,
Eleonora Molinaro Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Close
,
Gabriele Materazzi Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Endocrine Surgery, University Hospital of Pisa, Pisa, Italy

Search for other papers by Gabriele Materazzi in
Google Scholar
PubMed
Close
,
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Close
, and
Antonio Matrone Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Close

the disease is detected during the follow-up. According to the suggestions of the most recent ATA 2015 guidelines ( 1 ), the risk of recurrence should be redefined at each clinical control according to clinical, biochemical, and imaging evaluations. If

Open access
Grace Segall Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Grace Segall in
Google Scholar
PubMed
Close
,
Ravinder Singh Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Ravinder Singh in
Google Scholar
PubMed
Close
,
Min-Hua Jen Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Min-Hua Jen in
Google Scholar
PubMed
Close
,
Isaac Sanderson Adelphi Real World, Bollington, UK

Search for other papers by Isaac Sanderson in
Google Scholar
PubMed
Close
,
Alex Rider Adelphi Real World, Bollington, UK

Search for other papers by Alex Rider in
Google Scholar
PubMed
Close
,
Katie Lewis Adelphi Real World, Bollington, UK

Search for other papers by Katie Lewis in
Google Scholar
PubMed
Close
, and
Urpo Kiiskinen Eli Lilly and Company, Indianapolis, IN, USA

Search for other papers by Urpo Kiiskinen in
Google Scholar
PubMed
Close

). Germline RET mutations are present in up to 10% of patients with apparently sporadic MTCs ( 5 , 10 ). European Society for Medical Oncology (ESMO) guidelines recommend that screening for RET mutations should be strongly considered in all patients with

Open access
Andrea Leoncini Clinic for Radiology, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland

Search for other papers by Andrea Leoncini in
Google Scholar
PubMed
Close
,
Chiara Camponovo Thyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland

Search for other papers by Chiara Camponovo in
Google Scholar
PubMed
Close
,
Gaetano Paone Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland

Search for other papers by Gaetano Paone in
Google Scholar
PubMed
Close
,
Elena Gamarra Thyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland

Search for other papers by Elena Gamarra in
Google Scholar
PubMed
Close
,
Giorgio Treglia Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland

Search for other papers by Giorgio Treglia in
Google Scholar
PubMed
Close
, and
Pierpaolo Trimboli Thyroid Unit, Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland

Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed
Close

still recognized as the gold standard for detecting AFTN, authors suggested integrating TS in the TIRADS model to prevent UN-FNACs ( 10 , 12 , 13 ). However, the TIRADS-based strategy was proven highly accurate and guidelines recommend TS only in TN

Open access
Marine Sitbon Pharmacy Department, Hospital Saint-Louis APHP, Paris, France

Search for other papers by Marine Sitbon in
Google Scholar
PubMed
Close
,
Porhuoy Chou Endocrine Oncology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Porhuoy Chou in
Google Scholar
PubMed
Close
,
Seydou Bengaly Endocrine Oncology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Seydou Bengaly in
Google Scholar
PubMed
Close
,
Brigitte Poirot Department of Molecular Oncology, Saint-Louis Hospital (AP-HP), Université Paris Cité INSERM U 944, CNRS UMR 7212, Paris, France

Search for other papers by Brigitte Poirot in
Google Scholar
PubMed
Close
,
Marie Laloi-Michelin Department of Internal Medicine, Hospital Lariboisière APHP, Paris, France

Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Close
,
Laure Deville Pharmacy Department, Hospital Saint-Louis APHP, Paris, France

Search for other papers by Laure Deville in
Google Scholar
PubMed
Close
,
Atanas Pachev Radiology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Atanas Pachev in
Google Scholar
PubMed
Close
,
Ahouefa Kowo-Bille Endocrine Oncology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Ahouefa Kowo-Bille in
Google Scholar
PubMed
Close
,
Clement Dumont Medical Oncology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Clement Dumont in
Google Scholar
PubMed
Close
, and
Cécile N Chougnet Endocrine Oncology Department, Saint-Louis Hospital (AP-HP), Université Paris Cité, Paris, France

Search for other papers by Cécile N Chougnet in
Google Scholar
PubMed
Close

illustrates response to selpercatinib in vandetanib-naïve patients. The latest MTC guidelines suggest the benefit of molecular testing in all MTC cases ( 16 ), paving the way toward upfront-targeted treatment with RET-targeted agents. In addition, our case

Open access
Jaume Capdevila Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain

Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Close
,
Desiree’ Deandreis Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy

Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Close
,
Cosimo Durante Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy

Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Close
,
Sophie Leboulleux Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Close
,
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed
Close
,
Romana Netea-Maier Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Close
,
Kate Newbold Royal Marsden Hospital, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed
Close
,
Susanne Singer Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany

Search for other papers by Susanne Singer in
Google Scholar
PubMed
Close
,
Gerasimos P Sykiotis Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Close
,
Beate Bartes Association “Vivre sans Thyroïde”, Léguevin, France

Search for other papers by Beate Bartes in
Google Scholar
PubMed
Close
,
Kate Farnell Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK

Search for other papers by Kate Farnell in
Google Scholar
PubMed
Close
, and
Laura Deborah Locati Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy

Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Close

, location of metastases, and clinical status ( 8 ). A number of societies have issued guidance for the initiation of MKIs; however, their recommendations are not totally uniform. For example, the National Comprehensive Cancer Network guidelines recommend

Open access
Inês Damásio Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Inês Damásio in
Google Scholar
PubMed
Close
,
Joana Simões-Pereira Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Close
,
Sara Donato Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School, Lisbon, Portugal

Search for other papers by Sara Donato in
Google Scholar
PubMed
Close
,
Mariana Horta Radiology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon Portugal

Search for other papers by Mariana Horta in
Google Scholar
PubMed
Close
,
Branca Maria Cavaco Molecular Pathobiology Research Unit (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Close
,
Miguel Rito Pathology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Miguel Rito in
Google Scholar
PubMed
Close
,
Pedro Gomes Head and Neck Surgery Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Pedro Gomes in
Google Scholar
PubMed
Close
, and
Valeriano Leite Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close

represent a molecular target for cancer therapy, and the current American Thyroid Association (ATA) ( 4 ) ATC guidelines recommend analysis of somatic fusions in tumors without other candidate driver genes, such as BRAF. Currently, there are two drugs

Open access
Benjamin Chevalier Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Benjamin Chevalier in
Google Scholar
PubMed
Close
,
Oriane Karleskind Department of Pathology, Lille University Hospital, Lille, France

Search for other papers by Oriane Karleskind in
Google Scholar
PubMed
Close
,
Arnaud Jannin Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Arnaud Jannin in
Google Scholar
PubMed
Close
,
Olivier Farchi Department of Biochemistry and Molecular Biology, Hormonology Metabolism Nutrition Oncology, Lille University Hospital, Lille, France

Search for other papers by Olivier Farchi in
Google Scholar
PubMed
Close
,
Catherine Vermaut Department of Biochemistry and Molecular Biology, Hormonology Metabolism Nutrition Oncology, Lille University Hospital, Lille, France

Search for other papers by Catherine Vermaut in
Google Scholar
PubMed
Close
,
Alexandre Escande Academic Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center, Lille, France
CRIStAL UMR CNRS 9189, University of Lille, Villeneuve-d’Ascq, France

Search for other papers by Alexandre Escande in
Google Scholar
PubMed
Close
,
Clio Baillet Department of Nuclear Medicine, Lille University Hospital, Lille, France

Search for other papers by Clio Baillet in
Google Scholar
PubMed
Close
,
Stéphanie Espiard Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France
University of Lille, Lille, France
Institut National de la Santé et de la Recherche Médicale (INSERM), European Genomic Institute for Diabetes (EGID), CHU Lille, Lille, France

Search for other papers by Stéphanie Espiard in
Google Scholar
PubMed
Close
,
Marie-Christine Vantyghem Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France
University of Lille, Lille, France
Institut National de la Santé et de la Recherche Médicale (INSERM), European Genomic Institute for Diabetes (EGID), CHU Lille, Lille, France

Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed
Close
,
Bruno Carnaille University of Lille, Lille, France

Search for other papers by Bruno Carnaille in
Google Scholar
PubMed
Close
,
Emmanuelle Leteurtre University of Lille, Lille, France
Department of Pathology, Lille University Hospital, Lille, France
University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France

Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Close
, and
Christine Do Cao Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France

Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Close

(full list available in supplemental data) revealed a likely pathogenic variant (Class 4 according to the ACMG guidelines for the interpretation of sequence variants) in ATM (c.1123 A>T, p.(Arg375*)), resulting in an early stop codon ( 5 ). A variant

Open access